CD276 and triple-negative breast carcinoma: These nanobody-based B7-H3 CAR-T cells exhibited cytotoxicity against multiple solid tumors in vitro, including neuroblastoma (NB), pancreatic ductal adenocarcinoma (PDAC), triple-negative breast cancer and lung adenocarcinoma in an antigen-dependent manner.